Open access · OA via OpenAlex

Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies

Sheila M. Fleming, Ashley Davis, Emily Simons

Neuropharmacology · 2021 · ▲ 37 citations

Loss of proteostasis

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.neuropharm.2021.108870
Canonical: link ↗
Fetched: 2026-10-21 MST

Cite this

APA

Fleming, S.M., Davis, A., & Simons, E. (2021). Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies. <em>Neuropharmacology</em>. https://doi.org/10.1016/j.neuropharm.2021.108870

Vancouver

Fleming SM, Davis A, Simons E. Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies. Neuropharmacology. 2021. doi:10.1016/j.neuropharm.2021.108870.

BibTeX

@article{sheila2021Target, title = {Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies}, author = {Sheila M. Fleming and Ashley Davis and Emily Simons}, journal = {Neuropharmacology}, year = {2021}, doi = {10.1016/j.neuropharm.2021.108870}, }